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Abstract
Background: Genetic studies of complex disorders such as hypertension often utilize families
selected for this outcome, usually with information obtained at a single time point. Since age-at-
onset for diagnosed hypertension can vary substantially between individuals, a phenotype based on
long-term follow up in unselected families can yield valuable insights into this disorder for the
general population.
Methods: Genetic analyses were conducted using 2884 individuals from the largest 330 families of
the Framingham Heart Study. A longitudinal phenotype was constructed using the age at an
examination when systolic blood pressure (SBP) first exceeds 139 mm Hg. An interval for age-at-
onset was created, since the exact time of onset was unknown. Time-fixed (sex, study cohort) and
time-varying (body mass index, daily cigarette and alcohol consumption) explanatory variables were
included.
Results: Segregation analysis for a major gene effect demonstrated that the major gene effect
parameter was sensitive to the choice for age-at-onset. Linkage analyses for age-at-onset were
conducted using 1537 individuals in 52 families. Evidence for putative genes identified on
chromosome 17 in a previous linkage study using a quantitative SBP phenotype for these data was
not confirmed.
Conclusions: Interval censoring for age-at-onset should not be ignored. Further research is
needed to explain the inconsistent segregation results between the different age-at-onset models
(regressive threshold and proportional hazards) as well as the inconsistent linkage results between
the longitudinal phenotypes (age-at-onset and quantitative).
Background
Hypertension is a common yet complex disorder. Genetic
and environmental factors interacting over time are
thought to be important in its development. Many
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segregation and linkage studies utilize data from families
collected at a single time point. These cross-sectional stud-
ies will therefore include individuals who will become
hypertensive in the future, but who now have blood pres-
sure (BP) measurements considered to be within a normal
range.
To address the longitudinal aspect of this disorder, Levy et
al. [1] conducted a genome-wide scan to locate chromo-
somal regions linked to high BP, using the largest 332
Framingham Heart Study families. We note several points
related to their methods. First, the construction of a longi-
tudinal SBP phenotype for the 8478 subjects used the
mean SBP measurement, based on a minimum length of
follow-up and subject to age restrictions, with adjustment
for BMI. The residuals from a model that regressed the
within-subject mean SBP on the corresponding difference
of the mean age and body mass index (BMI) for each sub-
ject from the sample means formed the longitudinal SBP.
Second, observations from subjects who were being
treated for high blood pressure were included in the study.
Their observed BP measurements were adjusted using a
nonparametric transformation to yield values expected to
reflect their untreated BP measurements. Third, identity-
by-descent (IBD) sharing for untyped individuals with
phenotype information was inferred using SOLAR soft-
ware [2]. Lastly, tests for linkage were conducted using
variance components model as implemented in SOLAR.
The purpose of this current study is threefold: to assess the
impact of interval censoring; to compare outcomes from
two methods for segregation analyses using a longitudinal
phenotype for elevated SBP based on age-at-onset; and to
evaluate the evidence for linkage of this new phenotype to
two markers found by Levy et al. Three age-at-onset phe-
notypes were constructed to address the interval-censored
nature of the data, since ignoring this data feature can lead
to inaccurate conclusions in standard survival analyses
[3].
Methods
Study subjects
The Framingham Heart Study has been described in detail
previously [4,5]. The salient feature of the study that we
attempt to address is the periodic nature of the examina-
tions for the study subjects. Individuals enrolled when the
study began in 1948 had examinations repeated every 2
years. For subjects in the second cohort, which included
the offspring of the first cohort and their spouses, the sec-
ond examination took place 8 years after their enrollment.
Subsequent examinations occurred every 4 years, with a
final examination taking place 24 years after the first one.
Since families were initially enrolled without regard for
their hypertension status, they represent a random popu-
lation-based sample and no correction for ascertainment
was used.
Age-at-onset systolic BP phenotypes
The outcome of interest in this investigation is the age at
which systolic blood pressure (SBP) first exceeds 139 mm
Hg or when treatment for hypertension begins. Because
individuals treated for hypertension were classified as
having high SBP, imputation was not necessary. However,
since treatment could be initiated or SBP could have
become elevated at any time between the previous visit
where the SBP was found to be below the threshold and
the current visit where it was found to be above, an age
interval was created over which this event could have
occurred. Individuals experiencing elevated SBP during
the follow-up period could have three different ages at
onset: the upper end-point is the age when elevated SBP
or treatment was recorded, the lower end-point was the
age at the previous visit when blood pressure was meas-
ured and the midpoint was the average of the two end-
point ages.
In addition to interval censoring, the age-at-onset of high
SBP was also subject to right censoring when SBP was
always found to be less than 140 mm Hg during follow-
up. The sole age recorded for censored observations was
the earliest of age at death or end-of-study. Measured cov-
ariates included the fixed baseline covariates of sex and
cohort (original or offspring), while body mass index
(BMI), and daily alcohol and cigarette consumption were
treated as time-dependent covariates.
The number of individuals in the data set formed by com-
bining both cohorts with the age-at-onset information
was 2884. About 50% of these individuals (n = 1444)
experienced elevated SBP during the follow-up period.
The average upper age-at-onset for this group was 50.8
years (S.D. = 11.9 years), with onset ranging from 13 to 97
years. These descriptive values were very similar for the
lower age-at-onset (average = 49.6 years, S.D. = 11.8 years,
range 12–97 years) and, by construction, for the age mid-
way between these extremes (average = 50.2 years, S.D. =
11.8 years, range 13–97 years).
Segregation analyses
We applied two methods of segregation analyses: a pro-
portional hazards (PH) model with a frailty term [6,7]
and a regressive threshold model developed to account for
age-at-onset data [8,9].
We used three different definitions for age for onset
(upper, midpoint, lower), and either time-fixed covariates
(sex, cohort) alone or in conjunction with time varying
covariates (BMI, daily alcohol and cigarette consump-
tion). The baseline hazard function was approximated byBMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S84
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a step function over six age intervals (<40, 40–45, 45–50,
50–55, 55–60, >60). Using available software, maximum
likelihood estimation (MLE) of model parameters was
carried out assuming Hardy-Weinberg equilibrium, men-
delian transmission probabilities, and either a dominant
or recessive unmeasured gene segregating within families.
Proportional hazards model
This model, which is implemented in GAP, uses a frailty
term for an unmeasured diallelic major gene (MG) [6,7].
The baseline hazard function is approximated by a step
function on a user-specified number of intervals and all
covariates (measured and unmeasured) are assumed to
act multiplicatively on this baseline. Under Hardy-Wein-
berg equilibrium assumption, the population distribution
of genotypes depends only on the (unknown) allele fre-
quency. The transmission probabilities for each genotype
are fixed under the mendelian inheritance assumption.
Regressive threshold model (RTM)
The regressive model [10] is constructed by specifying a
regression relationship between each person's phenotype
and a set of explanatory variables including genotype at a
MG, phenotype of antecedents to account for unspecified
sources of residual family dependences (due to other
genes and/or shared environmental factors), and
observed covariates. For binary traits, Demenais [8] pro-
posed an alternative formulation of the regressive logistic
models that assumed an underlying liability to the disease
with a threshold determined from the morbid risk in the
population. The RTM has been recently extended to ana-
lyze diseases with variable age-of-onset by introducing
time-dependent thresholds [9]. The variation of risk with
age is modelled assuming a piece-wise constant hazard
function. Models can accommodate time-dependent cov-
ariates and include different parametric functions to
express the variation of the hazard with time. In this
study, we assume a constant displacement t and domi-
nance d for each age-class k (k = 1,...,6). The RTM formu-
lation was implemented in the package REGRESS [11,12],
which incorporates the regressive approach in the ILINK
program of the LINKAGE package [13]. Standard errors
for model parameters are available in this package but it
Table 1: Segregation Analysis Results for Three Age-at-onset Traits. Recessive Trait Parameter Estimates (S.E.) from Proportional 
Hazards Models(GAP) and Regressive Threshold Models (REGRESS)
Parameter
Two Covariates Five Covariates
Model UpperA Mid-pointB LowerC UpperA Mid-pointB LowerC
Proportional 
Hazards
Allele 
Frequency
0.76(.05) 0.78(.05) 0.81(.05)
Major GeneD 1.40(.13) 1.41(.14) 1.37(.15)
SexE 0.23(.07) 0.23(.06) 0.22(.06)
CohortF 0.52(.07) 0.52(.06) 0.53(.06)
-logL 6728 6764 6867
Regressive 
Threshold
Allele 
Frequency
0.50 0.55 0.52 0.55 0.51 0.51
Major GeneD 0.96 0.83 0.60 1.52 1.32 1.74
SexE 0.29 0.29 0.21 0.11 0.10 0.01
CohortF 0.01 0.01 -0.08 -0.02 0.01 -0.08
BMIG 0.05 0.05 0.05
SmokingH 0.02 0.02 0.05
DrinkingI 0.01 0.01 0.01
Parent-offspring 
corr
0.15 0.13 0.16 0.16 0.11 0.12
Sib-Sib corr 0.00 0.00 0.16 0.08 0.06 0.10
- l o g L 6 5 5 86 6 7 96 6 0 06 4 7 76 6 0 46 5 3 7
AUpper value from age interval. BValue at midpoint of interval. CLower value from age interval. DMajor gene effect is measured by the displacement 
(see Methods). E Sex variable (female vs. male). FCohort variable (offspring vs. original). GBody mass index (weight/height2 in kg/m2). HDaily cigarette 
consumption. IDaily alcohol consumption (g/day).BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S84
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was not possible to invert a large matrix of second partial
derivatives. Bootstrap samples can provide these variabil-
ity estimates, but require substantial running time.
Linkage analyses
These analyses were limited to the 52 largest families
(more than 20 individuals) due to the substantial compu-
tation time required to fit the RTM. About 30% of these
1537 individuals had genotype and phenotype informa-
tion. Generally, about 40% with no missing phenotype or
genotype information experienced high SBP during the
follow-up period individuals (versus 50% in the data set
with 330 families). However, the age discrepancies (aver-
age, S.D., and range) between the data with complete phe-
notype information and this subset appear to be minimal.
Due to sparse data, rare alleles were grouped for markers
that had more than five alleles in our analyses. Although
the REGRESS software can conduct multipoint linkage
analyses for a small number of markers, we conducted
two-point analyses to reduce computation time. Parame-
ter estimates from the segregation analyses assuming a
recessive trait were fixed in the linkage analyses.
Results and Discussion
Segregation analyses
Direct comparison of estimates obtained from the two
methods is not appropriate, however, their sensitivity to
the choice of age-at-onset is. Since there were small differ-
ences between the log likelihoods for the dominant and
recessive models, and the recessive models were used in
the subsequent linkage analyses because they had the larg-
est log likelihoods, only the results for the recessive mode
of inheritance are reported (Table 1). More extensive
model-fitting to determine a best-fitting model for these
data was not carried out.
Estimation of the cumulative penetrance among carriers for recessive mode of inheritance models Figure 1
Estimation of the cumulative penetrance among carriers for recessive mode of inheritance modelsBMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S84
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In the PH models, the allele frequency estimates become
progressively smaller as the age-at-onset changes from the
lowest possible value to the highest for each person, but
the differences are small relative to the standard errors. In
the RTM models, the major gene parameter estimates tend
to become progressively larger as the age-at-onset
increases.
The estimates for the measured covariates generally seem
robust to the choice of age-at-onset, except that the RTM
parameter estimates for the sex and cohort variables are
much smaller for the lower age-at-onset model. The
parameter estimates are much smaller when the lowest
age-at-onset is used in both the two-covariate and five-
covariate models than in the comparable middle and
upper ages-at-onset models. Based on likelihood ratio sta-
tistics, the five-variable models were clearly an improve-
ment over the two-variable models.
The estimated baseline penetrance risk functions (corre-
sponding to male carriers in Cohort 1) for the recessive
RTM are very similar for all three ages at onset, except at
age 50 (Figure 1). The PH curve for average age was similar
to that for RTM up to age 50.
Linkage analyses
The LOD scores for chromosome 17 marker GATA25A04
from the recessive RTM are generally quite small (0.03,
0.02, 0.11 for upper, midpoint, lower) compared to the
3.8 reported by Levy et al. The corresponding
recombination fractions (0.18, 0.50, 0.50) apparently
also depended on the age-at-onset definition, however it
Relationship between age-at-onset and average BP measurements models Figure 2
Relationship between age-at-onset and average BP measurements modelsBMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S84
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is difficult to draw conclusions about the effect of interval
censoring when there is no linkage signal. Findings for
chromosome 17 marker ATC6A06 were similar. None of
the significant findings by Levy et al. [1] were replicated in
our study. In addition to the differences in the construc-
tion of the longitudinal phenotypes and the linkage meth-
ods used, other possible explanations for these discrepant
findings include the numbers of families included in the
analyses and the handling of missing BP measurements.
Conclusions
These segregation and linkage analyses suggest that inter-
val censoring for the age-at-onset should not be ignored,
the choice of segregation method can affect some results,
and the type of longitudinal phenotype or linkage
method can affect linkage detection. Using different ages
at onset affected parameter estimates in the segregation
analyses related to the unknown major gene, as well as the
estimates of cumulative penetrances, and the estimated
recombination fraction in the linkage analyses. The segre-
gation results using lower age-at-onset appeared to be
most discordant with the other two age-at-onset values,
but further research is needed to provide practical
recommendations.
Further research is needed to understand the relevant dif-
ferences between the two segregation methods and the
two longitudinal phenotypes employed in this study. We
believe both constructed phenotypes should be picking
up similar longitudinal aspects of the onset of disease. In
the Levy et al. paper, each individual's average SBP would
be below or above the threshold of 139 mm Hg (indicated
by large green arrow on y-axis in Figure 2) which, in the
age-at-onset model, would correspond to a censored or
observed event, respectively (assuming a sufficient length
of follow-up for the age-at-onset phenotype; ages-at-onset
indicated by smaller green arrows on x-axis in Figure 2).
The curves in the plot represent three different lifetime
measures of SBP: 1) a person with a wild-type gene, 2) a
person with a baseline gene who has elevated SBP early in
life relative to person with a wildtype gene and maintains
this difference through-out his/her lifetime, and 3) a per-
son with "slope" gene who initially has the same SBP as a
person with a wild-type gene, but whose SBP increases at
a higher rate over his/her lifetime. By modeling time to
event more directly, we supposed that an age-at-onset
approach would also detect strong linkage signals due to
either early gene effects or effects that emerge with age.
Model-free methods may be more appropriate than
model-based methods for genome scans of complex dis-
eases. However, the latter may be of interest for confirm-
ing linkage results from model-free methods. It may also
be better in some cases to estimate jointly all the model
parameters, rather than in two stages. Simulation studies
directly comparing longitudinal phenotypes and various
methods of analyses (model-based versus model-free)
would help disentangle these differences and would guide
selection of phenotypes and analysis methods for other
outcomes with variable age-at-onset. Although the event
of elevated SBP is of clinical and therapeutic interest, and
its definition serves to circumvent the problem of BP lev-
els being modified by treatment, it is likely that informa-
tion from the quantitative measure is lost, yielding less
sensitive tests for genetic effects and larger sample size
requirements for comparable power. For disease
phenotypes in which quantitative measures are limited or
unreliable, further development of methods and software
for time-to-event outcomes and related longitudinal phe-
notypes would be welcome.
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